Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain

Nuclear Medicine and Biology
Zhiping ZhuangHank P Kung

Abstract

Formation and accumulation of excess aggregates of beta-amyloid (Abeta) plaques in the brain are critical factors contributing to the development and progression of Alzheimer's disease (AD). There is an urgent need for in vivo imaging agents that can specifically demonstrate the location and density of Abeta plaques in the brain. The aim of this study was to develop potential technetium 99m (99mTc)-labeled diagnostic imaging agents specific for the detection of Abeta plaques. Based on previously obtained Abeta plaque-specific biphenyls containing a p-N, N-dimethylaminophenyl group, a series of 99mTc and Re-N2S2-biphenyl derivatives was prepared. The stable neutral and lipophilic 99mTc complexes, [99mTc]19 and [99mTc]23, A+B, were successfully obtained. As surrogates for the 99mTc complexes, the corresponding surrogates, Re complexes of 23, were also prepared. Surprisingly, it was found that the Re complexes showed distinctively different retention profiles as compared with the corresponding 99mTc complexes. Biodistribution studies indicated that [99mTc]23A readily passed through the blood-brain barrier (1.18% dose/brain at 2 min) in contrast to the low brain penetration of [99mTc]19 (0.29% dose/brain at 2 min). Initial results ...Continue Reading

References

Jan 1, 1992·European Journal of Nuclear Medicine·J C Hung
Jan 1, 1992·Journal of Medicinal Chemistry·Y OhmomoH F Kung
Jul 1, 1996·Nuclear Medicine and Biology·S OyaH F Kung
Nov 7, 1999·European Journal of Nuclear Medicine·N A DezutterA M Verbruggen
Aug 10, 2000·Nature Biotechnology·D J Selkoe
Jun 1, 2001·Journal of Medicinal Chemistry·Z P ZhuangH F Kung
Dec 14, 2001·Journal of the American Chemical Society·H F KungK Plössl
Dec 26, 2001·Chemical Reviews·S S Jurisson, J D Lydon
Sep 18, 2002·Nuclear Medicine and Biology·Masahiro OnoHank F Kung
Aug 6, 2003·Nuclear Medicine and Biology·Chi-Wan LeeHank F Kung
Dec 23, 2003·Neuroscience Research·Takahiro SuemotoTohru Sawada
Mar 3, 2004·Annals of Neurology·William E KlunkBengt Långström
Mar 10, 2004·European Journal of Nuclear Medicine and Molecular Imaging·Mei-Ping KungHank F Kung
Mar 12, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nobuyuki OkamuraTohru Sawada
May 12, 2004·Current Pharmaceutical Design·C A MathisW E Klunk

❮ Previous
Next ❯

Citations

Aug 12, 2008·Molecular Neurobiology·Victor L VillemagneChristopher C Rowe
Nov 17, 2009·Bioinorganic Chemistry and Applications·Yang YangHuabei Zhang
May 24, 2011·International Journal of Molecular Imaging·Masahiro Ono, Hideo Saji
Mar 10, 2015·Dalton Transactions : an International Journal of Inorganic Chemistry·Jianhua JiaBoli Liu
Nov 29, 2015·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·André F MartinsCarlos F G C Geraldes
Apr 12, 2018·Current Medicinal Chemistry·Sajjad MolavipordanjaniSeyed Jalal Hosseinimehr
Feb 26, 2015·Chemistry : a European Journal·André F MartinsCarlos F G C Geraldes
Sep 24, 2020·Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology·Alexandre C OliveiraHugh D Burrows
Mar 14, 2009·Chemical Communications : Chem Comm·Mark BartholomäJon Zubieta
Mar 10, 2016·Journal of Labelled Compounds & Radiopharmaceuticals·M A MotalebM AbdAllah
Oct 3, 2018·International Journal of Radiation Biology·M H SanadOmaima A Hussain
Jul 15, 2021·Chemical Science·Elena SannaChristopher A Hunter
Nov 11, 2010·ACS Medicinal Chemistry Letters·Masahiro OnoMorio Nakayama

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.